483
Deerland Enzymes Inc.FDA 483 - Deerland Enzymes Inc. - December 23, 2014
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Deerland Enzymes Inc., a dietary supplement manufacturer in Kennesaw, GA, revealed significant deficiencies in manufacturing controls and facility sanitation. Observations included the absence of master manufacturing records, inadequate sampling of components, and improper storage of hazardous materials. The inspection also noted repeat observations regarding the accumulation of litter and waste, highlighting persistent issues.
- Office
- Atlanta District Office
Open in Dashboard
ID · ec5a6ec8-0539-47b8-83a4-668e0d011364